Select Publications
Journal articles
2021, 'The role of sodium glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease: A narrative review of potential mechanisms', Cells, 10, pp. 2699, http://dx.doi.org/10.3390/cells10102699
,2021, 'Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis', The Lancet, 398, pp. 1053 - 1064, http://dx.doi.org/10.1016/S0140-6736(21)01921-8
,2021, 'Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial', The Lancet, 398, pp. 1043 - 1052, http://dx.doi.org/10.1016/S0140-6736(21)01922-X
,2021, 'Effect of Salt Substitution on Cardiovascular Events and Death', New England Journal of Medicine, 385, pp. 1067 - 1077, http://dx.doi.org/10.1056/NEJMoa2105675
,2021, 'A Systematic Review of Salt Reduction Initiatives around the World: A Midterm Evaluation of Progress towards the 2025 Global Non-Communicable Diseases Salt Reduction Target', Advances in Nutrition, 12, pp. 1768 - 1780, http://dx.doi.org/10.1093/advances/nmab008
,2021, 'Barriers and facilitators to implementing reduced-sodium salts as a population-level intervention: A qualitative study', Nutrients, 13, pp. 3225, http://dx.doi.org/10.3390/nu13093225
,2021, 'Healthy Food Prescription Programs and their Impact on Dietary Behavior and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis', Advances in Nutrition, 12, pp. 1944 - 1956, http://dx.doi.org/10.1093/advances/nmab039
,2021, 'Protocol for the economic evaluation of the China Salt Substitute and Stroke Study (SSaSS)', BMJ Open, 11, pp. e045929, http://dx.doi.org/10.1136/bmjopen-2020-045929
,2021, 'Association of Baseline Diuretic Use With Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: A Secondary Analysis From TOPCAT', Journal of Cardiac Failure, 27, pp. 816 - 818, http://dx.doi.org/10.1016/j.cardfail.2021.02.010
,2021, 'Availability, formulation, labeling, and price of low-sodium salt worldwide: Environmental scan', JMIR Public Health and Surveillance, 7, pp. e27423, http://dx.doi.org/10.2196/27423
,2021, 'Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program', Endocrinology, Diabetes and Metabolism, 4, pp. e00247, http://dx.doi.org/10.1002/edm2.247
,2021, 'Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: A randomized, double-blind, controlled trial', American Journal of Clinical Nutrition, 114, pp. 185 - 193, http://dx.doi.org/10.1093/ajcn/nqab054
,2021, 'Influence of sugar label formats on consumer understanding and amount of sugar in food choices: A systematic review and meta-analyses', Nutrition Reviews, 79, pp. 788 - 801, http://dx.doi.org/10.1093/nutrit/nuaa108
,2021, 'Measuring the healthiness of ready-to-eat child-targeted cereals: Evaluation of the FoodsWitch platform in Sweden', JMIR mHealth and uHealth, 9, pp. e17780, http://dx.doi.org/10.2196/17780
,2021, 'Deconstructing the supermarket: Systematic ingredient disaggregation and the association between ingredient usage and product health indicators for 24,229 australian foods and beverages', Nutrients, 13, pp. 1882, http://dx.doi.org/10.3390/nu13061882
,2021, 'Feasibility and validity of using death surveillance data and SmartVA for fact and cause of death in clinical trials in rural China: A substudy of the China salt substitute and stroke study (SSaSS)', Journal of Epidemiology and Community Health, 75, pp. 540 - 549, http://dx.doi.org/10.1136/jech-2020-214063
,2021, 'The adaptation, validation, and application of a methodology for estimating the added sugar content of packaged food products when total and added sugar labels are not mandatory', Food Research International, 144, pp. 110329, http://dx.doi.org/10.1016/j.foodres.2021.110329
,2021, 'Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial', Circulation, 143, pp. 1735 - 1749, http://dx.doi.org/10.1161/CIRCULATIONAHA.120.048740
,2021, 'Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka', The Lancet Global Health, 9, pp. e660 - e667, http://dx.doi.org/10.1016/S2214-109X(21)00033-4
,2021, 'Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis', Stroke, 52, pp. 1545 - 1556, http://dx.doi.org/10.1161/STROKEAHA.120.031623
,2021, 'Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis', The Lancet, 397, pp. 1625 - 1636, http://dx.doi.org/10.1016/s0140-6736(21)00590-0
,2021, 'Prospective associations of the original Food Standards Agency nutrient profiling system and three variants with weight gain, overweight and obesity risk: Results from the French NutriNet-Santé cohort', British Journal of Nutrition, 125, pp. 902 - 914, http://dx.doi.org/10.1017/S0007114520003384
,2021, 'Sodium, Blood Pressure, and the Likely Massive Avoidable Burden of Cardiovascular Disease', Circulation, 143, pp. 1568 - 1570, http://dx.doi.org/10.1161/CIRCULATIONAHA.120.052654
,2021, 'Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial', Cardiovascular Research, 118, pp. 1103 - 1114, http://dx.doi.org/10.1093/cvr/cvab128
,2021, 'Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis', The Lancet Oncology, 22, pp. 558 - 570, http://dx.doi.org/10.1016/s1470-2045(21)00033-4
,2021, 'Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program', ESC Heart Failure, 8, pp. 1482 - 1493, http://dx.doi.org/10.1002/ehf2.13236
,2021, 'Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice', Kidney International, 99, pp. 999 - 1009, http://dx.doi.org/10.1016/j.kint.2020.10.042
,2021, 'POS-223 Clinical Utility of KidneyIntelX in Patients with Early Stages of Diabetic Kidney Disease in CANVAS Participants', Kidney International Reports, 6, pp. s93 - s94, http://dx.doi.org/10.1016/j.ekir.2021.03.237
,2021, 'Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial', American Heart Journal, 233, pp. 141 - 148, http://dx.doi.org/10.1016/j.ahj.2020.12.008
,2021, 'An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials', International Journal of Cardiology, 324, pp. 165 - 172, http://dx.doi.org/10.1016/j.ijcard.2020.09.050
,2021, 'Sodium Reduction: How Big Might the Risks and Benefits Be?', Heart Lung and Circulation, 30, pp. 180 - 185, http://dx.doi.org/10.1016/j.hlc.2020.07.011
,2021, 'Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes', Diabetes, Obesity and Metabolism, 23, pp. 382 - 390, http://dx.doi.org/10.1111/dom.14226
,2021, 'Availability, healthiness, and price of packaged and unpackaged foods in India: A cross-sectional study', Nutrition and Health, 28, pp. 571 - 579, http://dx.doi.org/10.1177/02601060211039124
,2021, 'Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study', Diabetes care, 44, pp. 210 - 216, http://dx.doi.org/10.2337/dc20-1889
,2021, 'Kidney, cardiovascular, and safety outcomes of canagliflozin according to baseline albuminuria a credence secondary analysis', Clinical Journal of the American Society of Nephrology, 16, pp. 384 - 395, http://dx.doi.org/10.2215/CJN.15260920
,2021, 'Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program', American Journal of Kidney Diseases, 77, pp. 23 - 34.e1, http://dx.doi.org/10.1053/j.ajkd.2020.06.018
,2021, 'Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 23, pp. 252 - 257, http://dx.doi.org/10.1111/dom.14197
,2021, 'Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol', American Heart Journal, 231, pp. 56 - 67, http://dx.doi.org/10.1016/j.ahj.2020.09.017
,2021, 'Vital signs during the COVID-19 outbreak: A retrospective analysis of 19,960 participants in Wuhan and four nearby capital cities in China', Global Heart, 16, pp. 47, http://dx.doi.org/10.5334/GH.913
,2021, 'Availability, Formulation, Labeling, and Price of Low-sodium Salt Worldwide: Environmental Scan (Preprint)', JMIR Public Health and Surveillance, 7, http://dx.doi.org/10.2196/27423
,2021, 'Canagliflozin and Cardiovascular Outcomes in Patients With and Without Peripheral Artery Disease At Baseline: Data from the CANVAS Program and CREDENCE Trials', Heart Lung and Circulation, 30, pp. s215, http://dx.doi.org/10.1016/j.hlc.2021.06.263
,2021, 'Corrigendum', ESC Heart Failure, 8, pp. 3447 - 3447, http://dx.doi.org/10.1002/ehf2.13408
,2021, 'Estimating the potential impact of Australia’s reformulation programme on households’ sodium purchases', BMJ Nutrition, Prevention & Health, 4, pp. 49 - 58, http://dx.doi.org/10.1136/bmjnph-2020-000173
,2020, 'Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study', Journal of the American College of Cardiology, 76, pp. 2982 - 3021, http://dx.doi.org/10.1016/j.jacc.2020.11.010
,2020, 'Effects of canagliflozin in patients with baseline eGFR <30 ml/min per 1.73 m2: Subgroup analysis of the randomized CREDENCE trial', Clinical Journal of the American Society of Nephrology, 15, pp. 1705 - 1714, http://dx.doi.org/10.2215/CJN.10140620
,2020, 'Correction to: Contribution of major food companies and their products to household dietary sodium purchases in Australia (International Journal of Behavioral Nutrition and Physical Activity, (2020), 17, 1, (81), 10.1186/s12966-020-00982-z)', International Journal of Behavioral Nutrition and Physical Activity, 17, pp. 159, http://dx.doi.org/10.1186/s12966-020-01064-w
,2020, 'The impact of voluntary front-of-pack nutrition labelling on packaged food reformulation: A difference-in-differences analysis of the Australasian Health Star Rating scheme', PLoS Medicine, 17, pp. e1003427, http://dx.doi.org/10.1371/journal.pmed.1003427
,2020, 'Effects of Canagliflozin on Amino-Terminal Pro–B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction', Journal of the American College of Cardiology, 76, pp. 2076 - 2085, http://dx.doi.org/10.1016/j.jacc.2020.09.004
,2020, 'Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial', The Lancet Diabetes and Endocrinology, 8, pp. 903 - 914, http://dx.doi.org/10.1016/s2213-8587(20)30300-4
,2020, 'Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program', Diabetes, Obesity and Metabolism, 22, pp. 2199 - 2203, http://dx.doi.org/10.1111/dom.14143
,